Presse Medicale

Papers
(The median citation count of Presse Medicale is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Editorial46
Editorial board42
Contents37
Pancreatic islet organoids and organoids on-chip for type 1 diabetes36
Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients34
Contents28
Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification27
History of measles24
International variability in the diagnosis and management of disorders of consciousness23
Autoimmunity in lipodystrophy syndromes21
Kidney disease in multiple myeloma21
Craniopharyngiomas20
Editorial board20
Editorial board20
Evolving strategies in the management of transplant-eligible patients with newly diagnosed multiple myeloma19
New developments in skin-directed treatments of cutaneous T-cell lymphoma18
Editorial board18
Familial partial lipodystrophy syndromes18
Molecular Imaging in neuroendocrine neoplasias17
Pulmonary hypertension in sickle cell disease17
Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma17
Towards etiological treatments in cardiomyopathies16
Editorial board15
The current and future contribution of neuroimaging to the understanding of disorders of consciousness15
Prognosis of consciousness disorders in the intensive care unit15
The deep and the deeper: Spinal cord and deep brain stimulation for neuropathic pain15
Cholera in Haiti14
Editorial board14
Presentation of polymyalgia rheumatica and large joint polyarthritis in the spectrum of hyper-IgG4-related disease: A case report and literature review14
Cystic fibrosis13
Heart failure with preserved ejection fraction: New challenges and new hopes13
Heart failure: A major public health problem12
Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact12
Cardiac functional imaging11
Editorial board11
Generalized lipoatrophy syndromes10
Contents10
Contents9
Adrenal functional imaging9
Contents9
Letter on the article “Long-COVID: Cognitive deficits (brain fog) and brain lesions in non hospitalized patients”9
The Spanish flu8
A tribute to Guy Meyer8
Risk stratification of acute pulmonary embolism8
COVID-19 and kidney transplantation8
Sickle cell disease and pregnancy8
Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments7
Prolactinomas7
Contents7
Elderly patients with venous thromboembolism: Insights from the RIETE registry7
Imaging in multiple myeloma7
Idiopathic pulmonary fibrosis6
Metreleptin treatment of non-HIV lipodystrophy syndromes6
Vascular pathophysiology of sickle cell disease6
Contents6
The liver in sickle cell disease5
Preventative and curative treatment of venous thromboembolic disease in cancer patients5
Bronchiectasis5
Diagnostic management of acute pulmonary embolism5
Health technology assessment in France5
HIV / AIDS as a model for emerging infectious disease: Origin, dating and circumstances of an emblematic epidemiological success4
Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management4
Functional imaging in thyroid cancer patients with metastases and therapeutic implications4
Treatment of elderly and frail myeloma patients4
Life and death of smallpox4
What's new in transplantation?4
Duration of anticoagulation of venous thromboembolism4
Recent insights in pituitary diseases3
Adrenocortical organoids: A promising tool for modelling human physiology and translational research3
The French way of HTA: Between scientific rigor, independence and transparency3
Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer3
Cushing's disease3
Primary ciliary dyskinesia3
Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years3
Hypophysitis: A comprehensive overview3
Multiple symmetric and multiple familial lipomatosis2
Functional imaging for hyperparathyroidism2
Editorial2
Neuropathic pain: Evidence based recommendations2
Editorial2
The European reference network on rare lung diseases (ERN-LUNG) ambition to offer better lung health for all2
Patient-reported outcome measures: A key to patient-tailored and outcome-driven care in pulmonary embolism survivors2
Chronic heart failure with reduced EF: A decade of major pharmacological innovations2
Yellow fever: A brief history of a tropical Virosis2
Clinical pharmacology of antidiabetic drugs: What can be expected of their use?2
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?2
Molecular imaging or functional: An increasingly applied method in all fields of medicine2
Contents2
Taking ethics into account: the HAS perspective2
Contents2
Electrical therapies in heart failure: Evolving technologies and indications2
0.11946892738342